1105039-51-7

Basic information

• Product Name: 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylic acid
• Synonyms: 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylic acid
• CAS NO: 1105039-51-7
• Molecular Weight: 300.237
• Mol File: 1105039-51-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylic acid(1105039-51-7)
• EPA Substance Registry System: 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylic acid(1105039-51-7)

Safety Data

• Hazardous Substances Data: 1105039-51-7(Hazardous Substances Data)

Upstream product

• 1105039-92-6 ethyl 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylate 
• 1105039-91-5 ethyl 1-(4-methoxybenzyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate 
• 824-94-2 p-methoxybenzyl chloride 
• 155377-19-8 ethyl 3-trifluoromethyl-1H-pyrazole-4-carboxylate 

Downstream Products

• 1105039-54-0 1-(4-methoxybenzyl)-3-(trifluoromethyl)-1H-pyrazole-4-carbonyl chloride 
• 1105039-52-8 1-(4-methoxybenzyl)-5-(trifluoromethyl)-1H-pyrazole-4-carbonyl chloride 
• 1227070-36-1 N-(1-(6-(4-fluorophenyl)-4,5-dimethylpyridazin-3-yl)piperidin-4-yl)-1-(4-methoxybenzyl)-N-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide 
• 1525641-12-6 [3-(trifluoromethyl)-1H-pyrazol-4-yl]methanamine 
• 1105039-56-2 2-bromo-1-(1-(4-methoxybenzyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl)ethanone 
• 1105039-55-1 2-bromo-1-(1-(4-methoxybenzyl)-3-(trifluoromethyl)-1H-pyrazol-4-yl)ethanone 

Relevant articles and documents

ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION

The present invention relates to novel compounds of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds as DNA gyrase and/or topoisomerase IV inhibitors in the treatment and/or prophylaxis of bacterial infection.

TETRASUBSTITUTED PYRIDAZINE HEDGEHOG PATHWAY ANTAGONISTS

The present invention provides novel tetrasubstituted pyridine hedgehog pathway antagonists of the following formula I (I) or a pharmaceutically acceptable salt thereof, wherein: X is C-R1 or N; R1 is hydrogen, fluoro or cyano; Rsup

NOVEL HETEROAROMATIC DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS

The present invention relates to novel compounds of Formula (I), wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4, M1, M2, M3, Am and